Prostate cancer - chemoprevention

2009-09-01

European Journal of Cancer , Volume 45 - Issue SUPPL. 1 p. 355- 359

Additional Metadata
Keywords	alpha tocopherol, article, cancer growth, cancer incidence, cancer mortality, cancer risk, chemoprophylaxis, clinical trial, colorectal cancer, diabetes mellitus, digital rectal examination, disease duration, drug dose comparison, dutasteride, finasteride, high risk population, human, lung cancer, lycopene, placebo, primary prevention, priority journal, prognosis, prostate cancer, prostate specific antigen, quercetin, secondary prevention, selenium, skin carcinoma, vitamin supplementation
Persistent URL	doi.org/10.1016/S0959-8049(09)70050-4, hdl.handle.net/1765/17554
Journal	European Journal of Cancer
Organisation	Erasmus MC: University Medical Center Rotterdam
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Schröder, F., & van Weerden, W. (2009). Prostate cancer - chemoprevention. European Journal of Cancer, 45(SUPPL. 1), 355–359. doi:10.1016/S0959-8049(09)70050-4

Publication